Home Archives 2009 October

Monthly Archives: October 2009

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology:

Why data exclusivity is the new patent protection
Peter J Pitts, Center for medicine in the public interest

Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski(a) and Elizabeth A Jex(b)
a) Office of Policy Planning, Federal Trade Commission
b) FTC Office of Policy Planning

I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.

This fellowship will allow me to attend the Kyoto Prize Ceremony, laureate lectures and workshops, and associated functions. The Kyoto Prize is one of the world’s most prestigious awards given to those who have made outstanding lifetime achievements in technology, science, or the arts. This year’s laureates are:

Dr. Isamu Akasaki, Blue LED pioneer

Drs. Peter and Rosemary Grant, Evolutionary Biologists

Pierre Boulez, World-renowned composer, conductor

I am honored to have the opportunity to attend this prestigious event and to learn more about innovation in diverse disciplines.

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in October 2009

TradenameApplicantGeneric NamePatent NumberPatent Expiration
BREATHTEK UBT FOR H-PYLORIOtsuka Americaurea, c-134,830,010Oct 27, 2009
CEDAXSciele Pharma Incceftibuten dihydrate4,634,697Oct 1, 2009
COLGATE TOTALColgate Palmolivesodium fluoride; triclosan5,156,835Oct 20, 2009
COVERA-HSGd Searle Llcverapamil hydrochloride5,785,994Oct 22, 2009
DOXILOrtho Biotechdoxorubicin hydrochloride5,013,556Oct 20, 2009
DOXILOrtho Biotechdoxorubicin hydrochloride5,213,804Oct 20, 2009
FLOMAXBoehringer Ingelheimtamsulosin hydrochloride4,703,063Oct 27, 2009
INVEGA SUSTENNAJohnson And Johnsonpaliperidone palmitate5,254,556Oct 27, 2009
MERETEK UBT KIT (W/ PRANACTIN)Otsuka Americaurea, c-134,830,010Oct 27, 2009
PERMAXValeant Pharm Intlpergolide mesylate5,114,948Oct 19, 2009

*Drugs may be covered by multiple patents

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.